Global Huntingtons Disease Therapeutics Market Study 2015-2025, by Segment (Antidopaminergics, Anticonvulsants, Antipsychotics, … …), by Market (Hosptial, Clinic, Research), by Company (Auspex Pharmaceuticals, Alnylam Pharmaceuticals, Intellect Neurosciences Incorporation, … …)

Published by 99Strategy on 6th December 2018 | Ref: 1108541 | This Report Is In Stock

$1800 | Single User
$3600 | Site License
$3600 | Enterprise License
$1800 | Single User
$3600 | Site License
$3600 | Enterprise License

Introduction

Snapshot

The global Huntingtons Disease Therapeutics market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Antidopaminergics

Anticonvulsants

Antipsychotics

Antidepressants

Demand Coverage (Market Size & Forecast, Consumer Distribution):

Hosptial

Clinic

Research

Company Coverage (Sales data, Main Products & Services etc.):

Auspex Pharmaceuticals

Alnylam Pharmaceuticals

Intellect Neurosciences Incorporation

H. Lundbeck

Prana Biotechnology Limited

Raptor Pharmaceuticals

Sangamo Biosciences

Teva Pharmaceutical Industries

Trophos SA

Valeant Pharmaceuticals International

Vertex Pharmaceuticals

Roche

Major Region Market

North America

Europe

Asia-Pacific

South America

Middle East & Africa

Table of Contents

Table of Content

1 Industry Overview

1.1 Huntingtons Disease Therapeutics Industry

1.2 Market Segment

1.3 Price & Cost Overview

2 Huntingtons Disease Therapeutics Market by Type

2.1 By Type

2.2 Market Size by Type

2.3 Market Forecast by Type

3 Global Market Demand

3.1 Segment Overview

3.2 Market Size by Demand

3.3 Market Forecast by Demand

4 Major Region Market

4.1 Global Market Overview

4.2 Major Region

5 Major Companies List

5.1 Auspex Pharmaceuticals (Company Profile, Sales Data etc.)

5.2 Alnylam Pharmaceuticals (Company Profile, Sales Data etc.)

5.3 Intellect Neurosciences Incorporation (Company Profile, Sales Data etc.)

5.4 H. Lundbeck (Company Profile, Sales Data etc.)

5.5 Prana Biotechnology Limited (Company Profile, Sales Data etc.)

5.6 Raptor Pharmaceuticals (Company Profile, Sales Data etc.)

5.7 Sangamo Biosciences (Company Profile, Sales Data etc.)

5.8 Teva Pharmaceutical Industries (Company Profile, Sales Data etc.)

5.9 Trophos SA (Company Profile, Sales Data etc.)

5.10 Valeant Pharmaceuticals International (Company Profile, Sales Data etc.)

5.11 Vertex Pharmaceuticals (Company Profile, Sales Data etc.)

5.12 Roche (Company Profile, Sales Data etc.)

6 Conclusion

Additional Details

Publisher

99Strategy

Publisher Information

Reference

1108541 | 99SHea20181816888

Number of Pages

54

Report Format

PDF

This report is published by 99Strategy

Download Free Report Summary PDF

Global Huntingtons Disease Therapeutics Market Study 2015-2025, by Segment (Antidopaminergics, Anticonvulsants, Antipsychotics, … …), by Market (Hosptial, Clinic, Research), by Company (Auspex Pharmaceuticals, Alnylam Pharmaceuticals, Intellect Neurosciences Incorporation, … …) [Updated: 06-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.